These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 33838126

  • 1. Glucocorticoids suppressed osteoblast differentiation by decreasing Sema3A expression via the PIK3/Akt pathway.
    Xing Q, Feng J, Zhang X.
    Exp Cell Res; 2021 Jun 01; 403(1):112595. PubMed ID: 33838126
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Melatonin rescues glucocorticoid-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways.
    Zhao R, Tao L, Qiu S, Shen L, Tian Y, Gong Z, Tao ZB, Zhu Y.
    Life Sci; 2020 Sep 15; 257():118044. PubMed ID: 32622944
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Semaphorin 3A promotes the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells in inflammatory environments by suppressing the Wnt/β-catenin signaling pathway.
    Sun Z, Yan K, Liu S, Yu X, Xu J, Liu J, Li S.
    J Mol Histol; 2021 Dec 15; 52(6):1245-1255. PubMed ID: 33566267
    [Abstract] [Full Text] [Related]

  • 6. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway.
    Deng S, Dai G, Chen S, Nie Z, Zhou J, Fang H, Peng H.
    Biomed Pharmacother; 2019 Feb 15; 110():602-608. PubMed ID: 30537677
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis.
    Mediero A, Wilder T, Shah L, Cronstein BN.
    FASEB J; 2018 Jul 15; 32(7):3487-3501. PubMed ID: 29394106
    [Abstract] [Full Text] [Related]

  • 9. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
    Li H, Li T, Fan J, Li T, Fan L, Wang S, Weng X, Han Q, Zhao RC.
    Cell Death Differ; 2015 Dec 15; 22(12):1935-45. PubMed ID: 26206089
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. microRNA-199a counteracts glucocorticoid inhibition of bone marrow mesenchymal stem cell osteogenic differentiation through regulation of Klotho expression in vitro.
    Tang J, Yu H, Wang Y, Duan G, Wang B, Li W, Zhu Z.
    Cell Biol Int; 2020 Dec 15; 44(12):2532-2540. PubMed ID: 32869899
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phloretin Suppresses Bone Morphogenetic Protein-2-Induced Osteoblastogenesis and Mineralization via Inhibition of Phosphatidylinositol 3-kinases/Akt Pathway.
    Takeno A, Kanazawa I, Tanaka KI, Notsu M, Sugimoto T.
    Int J Mol Sci; 2019 May 20; 20(10):. PubMed ID: 31137461
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein D alleviates glucocorticoid-induced osteogenesis suppression in bone marrow mesenchymal stem cells via the PI3K/Akt pathway.
    Yu RH, Zhang XY, Xu W, Li ZK, Zhu XD.
    J Orthop Surg Res; 2020 Aug 08; 15(1):307. PubMed ID: 32771037
    [Abstract] [Full Text] [Related]

  • 19. Cornuside I promoted osteogenic differentiation of bone mesenchymal stem cells through PI3K/Akt signaling pathway.
    Gao F, Xia SL, Wang XH, Zhou XX, Wang J.
    J Orthop Surg Res; 2021 Jun 21; 16(1):397. PubMed ID: 34154621
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.